NO147306C - Analogifremgangsmaate ved fremstilling av nye, farmakologisk aktive piperazinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av nye, farmakologisk aktive piperazinderivater

Info

Publication number
NO147306C
NO147306C NO774294A NO774294A NO147306C NO 147306 C NO147306 C NO 147306C NO 774294 A NO774294 A NO 774294A NO 774294 A NO774294 A NO 774294A NO 147306 C NO147306 C NO 147306C
Authority
NO
Norway
Prior art keywords
preparation
pharmacologically active
piperazine derivatives
analogy procedure
new pharmacologically
Prior art date
Application number
NO774294A
Other languages
English (en)
Other versions
NO774294L (no
NO147306B (no
Inventor
Karoly Felfoeldi
Jozsef Apjok
Mihaly Bartok
Jozsef Czombos
Arpad Molnar
Ferenc Noteisz
Egon Karpati
Laszlo Szporny
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO774294L publication Critical patent/NO774294L/no
Publication of NO147306B publication Critical patent/NO147306B/no
Publication of NO147306C publication Critical patent/NO147306C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO774294A 1976-12-15 1977-12-14 Analogifremgangsmaate ved fremstilling av nye, farmakologisk aktive piperazinderivater NO147306C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76RI605A HU174215B (hu) 1976-12-15 1976-12-15 Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej

Publications (3)

Publication Number Publication Date
NO774294L NO774294L (no) 1978-06-16
NO147306B NO147306B (no) 1982-12-06
NO147306C true NO147306C (no) 1983-03-16

Family

ID=11001009

Family Applications (1)

Application Number Title Priority Date Filing Date
NO774294A NO147306C (no) 1976-12-15 1977-12-14 Analogifremgangsmaate ved fremstilling av nye, farmakologisk aktive piperazinderivater

Country Status (21)

Country Link
US (2) US4140790A (no)
JP (2) JPS6026114B2 (no)
AT (1) AT359507B (no)
BE (1) BE861849A (no)
CA (1) CA1080219A (no)
CH (1) CH632750A5 (no)
DE (1) DE2755707A1 (no)
ES (1) ES465061A1 (no)
FI (1) FI65427C (no)
FR (1) FR2374322A1 (no)
GB (1) GB1580227A (no)
HU (1) HU174215B (no)
IL (1) IL53552A (no)
IN (1) IN146474B (no)
NL (1) NL7713827A (no)
NO (1) NO147306C (no)
PT (1) PT67403B (no)
SE (1) SE430159B (no)
SU (1) SU694071A3 (no)
YU (1) YU293677A (no)
ZA (1) ZA777398B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174215B (hu) * 1976-12-15 1979-11-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej
US4703120A (en) * 1986-04-28 1987-10-27 Ortho Pharmaceutical Corporation Furo(3,4-d)pyrimidine-2,4-dione derivatives and intermediates thereof
CN1060168C (zh) * 1994-05-06 2001-01-03 中国人民解放军军事医学科学院毒物药物研究所 新的呫吨衍生物,其制备方法及含它们的药物组合物
PL371486A1 (en) 2002-02-01 2005-06-13 Astrazeneca Ab Quinazoline compounds
CA2521330A1 (en) * 2003-04-08 2004-10-21 Neuromed Technologies, Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US20080207738A1 (en) * 2007-02-28 2008-08-28 Cancure Laboratories, Llc Drug combinations to treat drug resistant tumors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481930A (en) * 1966-11-21 1969-12-02 American Home Prod Xanthene and thioxanthene-9 ureas and propionamides
US3502662A (en) * 1968-03-18 1970-03-24 American Home Prod N-(9-xanthenyl or thioxanthenyl)-3-amino or iodo-propionamides and 4-(9-xanthenyl or thioxanthenyl)-thiosemicarbazones
FR2201084B1 (no) * 1972-09-29 1975-10-31 Bouchara Emile
US3953449A (en) * 1973-05-09 1976-04-27 Synthelabo 2-(4-M-CF3 or -SCF3 phenylpiperazino)-ethyl benzoates
HU174215B (hu) * 1976-12-15 1979-11-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej

Also Published As

Publication number Publication date
DE2755707A1 (de) 1978-06-29
NO774294L (no) 1978-06-16
BE861849A (fr) 1978-03-31
IL53552A (en) 1981-07-31
SE430159B (sv) 1983-10-24
JPS5377073A (en) 1978-07-08
PT67403A (en) 1978-01-01
NL7713827A (nl) 1978-06-19
FR2374322A1 (fr) 1978-07-13
YU293677A (en) 1982-08-31
GB1580227A (en) 1980-11-26
PT67403B (en) 1979-05-21
AT359507B (de) 1980-11-10
SE7713906L (sv) 1978-06-16
IN146474B (no) 1979-06-16
FI773743A (fi) 1978-06-16
ATA867677A (de) 1980-04-15
FI65427B (fi) 1984-01-31
ZA777398B (en) 1978-10-25
US4140790A (en) 1979-02-20
IL53552A0 (en) 1978-03-10
CH632750A5 (de) 1982-10-29
ES465061A1 (es) 1979-01-01
JPS6026114B2 (ja) 1985-06-21
US4250310A (en) 1981-02-10
HU174215B (hu) 1979-11-28
NO147306B (no) 1982-12-06
JPS5377080A (en) 1978-07-08
FI65427C (fi) 1984-05-10
SU694071A3 (ru) 1979-10-25
FR2374322B1 (no) 1981-11-27
CA1080219A (en) 1980-06-24

Similar Documents

Publication Publication Date Title
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO154919C (no) Analogifremgangsmaate ved fremstilling av nye kinazolinderivater.
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO149733C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO143846C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater
NO154426C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.
NO148416C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater
NO148642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO153725C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-(nafthylmethyl)-piperidin-derivater.
NO148926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater
NO142625C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater
NO150882C (no) Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater
NO154920C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner.
NO149388C (no) Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater